Trimetaphan nitroprusside
Latest Information Update: 30 Aug 2002
At a glance
- Originator Nonindustrial source
- Class Heart failure therapies; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 19 Feb 2002 Discontinued-unspecified phase for Heart Failure in Switzerland